Experimental Hematology Group - VHIO

VHIO’s Experimental Hematology Group conducts translational, pre-clinical and clinical research on hematological neoplasms of both lymphoid and myeloid origin. Our research team is composed of hematologists and biological scientists who work closely together to design, conduct and lead our programs.

Molecular Oncology Group - VHIO

Cancers, Free Full-Text

Conservation of copy number profiles during engraftment and

Societat Catalana d'Immunologia on X: 📢 El @VHIO busca

Experimental Hematology Group - VHIO

Hematologia - Hospital Universitari Vall d'Hebron (@Hemato_Vhebron

PDF) Recent Advances in the Targeting of Epigenetic Regulators in

COVID-19 in adult acute myeloid leukemia patients: a long-term

The 49th Annual Meeting of the European Society for Blood and

The FANCM:p.Arg658* truncating variant is associated with risk of

Molecular Oncology Group - VHIO

Carlota Pagès Geli - PHD Candidate - Vall d´Hebron Institute of

Axicabtagene ciloleucel compared to tisagenlecleucel for the